Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bowers

Showing results (291-300 of 314) with videos related to

Pageof 32
Sort By:
Cancers|February 13, 2020
Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in <i>BRCA1, BRCA2</i>, and <i>TP53</i> Genes in Women with Very Early-Onset (<36 Years) Breast CancerZerin Hyder, Elaine F Harkness, Emma R Woodward, et al.
Neurology|November 19, 2016
Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosisMiriam J Smith, Naomi L Bowers, Michael Bulman, et al.
Human Mutation|March 25, 2022
Re-evaluation of missense variant classifications in NF2Katherine V Sadler, Charlie F Rowlands, Philip T Smith, et al.
Clinical Genetics|September 11, 2019
A deep intronic SMARCB1 variant associated with schwannomatosisMiriam J Smith, Naomi L Bowers, Catherine Banks, et al.
Familial Cancer|June 27, 2019
Multiple primary malignancies associated with a germline SMARCB1 pathogenic variantJudith A Eelloo, Miriam J Smith, Naomi L Bowers, et al.
Cancers|August 27, 2021
Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior <i>BRCA1/2</i> ProbabilityD Gareth Evans, Elke M van Veen, Emma R Woodward, et al.
Cancer Medicine|July 29, 2016
Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)Ace J Hatch, Alexander B Sibley, Mark D Starr, et al.
Molecular and Cellular Biology|May 9, 2002
mtCLIC/CLIC4, an organellular chloride channel protein, is increased by DNA damage and participates in the apoptotic response to p53Ester Fernández-Salas, Kwang S Suh, Vladislav V Speransky, et al.
Familial Cancer|March 25, 2021
Extended gene panel testing in lobular breast cancerElke M van Veen, D Gareth Evans, Elaine F Harkness, et al.
Journal of Medical Genetics|February 1, 2011
Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onsetMiriam J Smith, Jenny E Higgs, Naomi L Bowers, et al.
Pageof 32

Showing results (291-300 of 314) with videos related to

Sort By:
Pageof 32
Cancers|February 13, 2020
Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in <i>BRCA1, BRCA2</i>, and <i>TP53</i> Genes in Women with Very Early-Onset (<36 Years) Breast CancerZerin Hyder, Elaine F Harkness, Emma R Woodward, et al.
Neurology|November 19, 2016
Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosisMiriam J Smith, Naomi L Bowers, Michael Bulman, et al.
Human Mutation|March 25, 2022
Re-evaluation of missense variant classifications in NF2Katherine V Sadler, Charlie F Rowlands, Philip T Smith, et al.
Clinical Genetics|September 11, 2019
A deep intronic SMARCB1 variant associated with schwannomatosisMiriam J Smith, Naomi L Bowers, Catherine Banks, et al.
Familial Cancer|June 27, 2019
Multiple primary malignancies associated with a germline SMARCB1 pathogenic variantJudith A Eelloo, Miriam J Smith, Naomi L Bowers, et al.
Cancers|August 27, 2021
Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior <i>BRCA1/2</i> ProbabilityD Gareth Evans, Elke M van Veen, Emma R Woodward, et al.
Cancer Medicine|July 29, 2016
Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)Ace J Hatch, Alexander B Sibley, Mark D Starr, et al.
Molecular and Cellular Biology|May 9, 2002
mtCLIC/CLIC4, an organellular chloride channel protein, is increased by DNA damage and participates in the apoptotic response to p53Ester Fernández-Salas, Kwang S Suh, Vladislav V Speransky, et al.
Familial Cancer|March 25, 2021
Extended gene panel testing in lobular breast cancerElke M van Veen, D Gareth Evans, Elaine F Harkness, et al.
Journal of Medical Genetics|February 1, 2011
Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onsetMiriam J Smith, Jenny E Higgs, Naomi L Bowers, et al.
Pageof 32